Association between WHO cut-offs for childhood overweight and obesity and cardiometabolic risk

Mercedes de Onis1, Cecilia Martínez-Costa, Francisco Núñez

  • 1Department of Nutrition, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland. deonism@who.int

Public Health Nutrition
|November 1, 2012
PubMed

Insights

Childhood overweight and obesity, defined by WHO BMI standards, are linked to increased cardiovascular risk factors. Early prevention is crucial for reducing long-term health issues.

Area of Science:

  • Pediatric endocrinology
  • Cardiovascular health
  • Metabolic disorders

Background:

  • Childhood overweight and obesity are growing global health concerns.
  • The World Health Organization (WHO) provides standardized BMI-for-age references for classification.
  • Identifying early cardiovascular risk in children is vital for preventative strategies.

Purpose of the Study:

  • To investigate the association between childhood overweight/obesity and cardiovascular risk markers.
  • To utilize WHO BMI cut-offs for classifying children's weight status.
  • To compare metabolic and vascular risk factors across different BMI categories.

Main Methods:

  • Classification of 149 children (aged 8-18) into normal weight, overweight, and obese groups using WHO BMI-for-age criteria.
  • Comparison of blood pressure, lipid profiles, glucose, insulin, HOMA-IR, and uric acid levels across BMI groups.
  • Statistical analysis including ANOVA, tests of linearity, and calculation of odds ratios for adverse biochemical markers.

Main Results:

  • 41% of children were classified as obese, 22% as overweight, and 37% as normal weight.
  • Significant linear differences in systolic blood pressure, HDL-cholesterol, triglycerides, insulin, HOMA-IR, and uric acid were observed across BMI groups.
  • Obese children showed significantly higher odds for hypertension, high insulin, HOMA-IR, and dyslipidemia compared to normal-weight children. Overweight children also exhibited increased risks.

Conclusions:

  • WHO BMI-for-age cut-offs effectively identify children with elevated metabolic and vascular risks.
  • Childhood overweight and obesity are strongly associated with multiple cardiovascular risk factors.
  • Preventing overweight and obesity in children is essential for mitigating future cardiovascular disease risk.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...